By: Alex Knapp
In this week's edition of InnovationRx, we look at the Trump administration's moves on medical marijuana and psychedelics, a new partnership, a brain implant deal, and more.


Alex Knapp is a Senior Editor at Forbes, covering healthcare, science, and cutting-edge technology. His work encompasses a range of topics including artificial intelligence, healthcare technology, and cultural trends, with a particular focus on the intersections of medicine and society. Alex's insights and reporting have been featured in KXLY-TV, Forbes Australia, Forbes Middle East, Forbes India, Yahoo Finance, RamaOnHealthcare, and Yahoo.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston


Not enough data
Alex Knapp's coverage encompasses a variety of topics including healthcare, pharmaceuticals, sustainability, and innovation. He frequently focuses on groundbreaking startups, funding rounds, and innovative technologies within these fields.
Given the prevalence of press releases and data citations in his articles, it seems that Alex would be interested in receiving pitches related to new product launches or research findings supported by robust data. Additionally, he might also be open to stories about companies making significant contributions to healthcare or sustainability sectors.
As for government announcements being part of his coverage attributes at 11%, this suggests potential responsiveness to news regarding policy changes impacting the covered industries. Whether it’s advancements in biotech research or innovations within the space economy sector; they are all likely areas where Alex may respond well to well-pitched stories.
This information evolves through artificial intelligence and human feedback. Improve this profile .